Clinical Advances in Nasopharyngeal Carcinoma : Episode 8
Opinion
Video
Future Research Needs for Neoadjuvant/Adjuvant PD-1 Blockade in Nasopharyngeal Carcinoma
Author(s):
The panel provides clinical insights on nasopharyngeal carcinoma treatment practices and outlines unmet needs in the current therapeutic landscape.
EP: 1.Differentiating Nasopharyngeal Carcinoma from Other Head & Neck Cancers: The Value of a Multidisciplinary Approach
EP: 2.Current Guidelines for Managing Nasopharyngeal Carcinoma
EP: 3.Overview of the JUPITER and POLARIS-2 Trials
EP: 4.Value of PD-L1 Biomarker in NPC
EP: 5.Phase 3 DIPPER Trial: Adjuvant PD-1 Blockade with Camrelizumab
EP: 6.Tailoring NPC Treatment: Patient Populations, EBV Titer Monitoring, and Key External Factors
EP: 7.Strategies to Mitigate Adverse Events in Nasopharyngeal Carcinoma Treatment
Now Viewing
EP: 8.Future Research Needs for Neoadjuvant/Adjuvant PD-1 Blockade in Nasopharyngeal Carcinoma
Video content above is prompted by the following:
- What further research is needed to better understand the long-term benefits and risks of neoadjuvant/adjuvant PD-1 blockade this patient population?
Related Videos
Related Content
